Order Article Reprints

Zizzari IG, Di Filippo A, Scirocchi F, Di Pietro FR, Rahimi H, Ugolini A, Scagnoli S, Vernocchi P, Del Chierico F, Putignani L, et al. Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients. Journal of Personalized Medicine. 2020; 10(4):208. https://doi.org/10.3390/jpm10040208

Zizzari, Ilaria Grazia, Alessandra Di Filippo, Fabio Scirocchi, Francesca Romana Di Pietro, Hassan Rahimi, Alessio Ugolini, Simone Scagnoli, Pamela Vernocchi, Federica Del Chierico, Lorenza Putignani, and et al. 2020. "Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients" Journal of Personalized Medicine 10, no. 4: 208. https://doi.org/10.3390/jpm10040208

Zizzari, I. G., Di Filippo, A., Scirocchi, F., Di Pietro, F. R., Rahimi, H., Ugolini, A., Scagnoli, S., Vernocchi, P., Del Chierico, F., Putignani, L., Rughetti, A., Marchetti, P., Nuti, M., Botticelli, A., & Napoletano, C. (2020). Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients. Journal of Personalized Medicine, 10(4), 208. https://doi.org/10.3390/jpm10040208